Literature DB >> 33138968

Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer.

Tsunehiko Maruyama1, Mitsugi Shimoda2, Hiroyuki Hakoda3, Akihiro Sako3, Kazumitsu Ueda4, Shuji Suzuki2.   

Abstract

BACKGROUND: Preoperative nutritional and inflammatory indices have been reported to be associated with the prognosis of patients with malignancy. We evaluated clinicopathological factors, including nutritional and inflammatory indices, and recurrence prognosis in patients with stage IIA colon cancer (CC) who underwent curative surgery.
METHODS: This retrospective study included 197 patients with stage IIA CC who had undergone curative resection. We evaluated the association between prognostic nutritional index (PNI), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) with clinicopathological factors and prognosis for recurrence. For the recurrence-free survival (RFS) analysis, receiver operating characteristic (ROC) curves were used to determine appropriate cutoff values for PNI, NLR, and PLR.
RESULTS: Univariate analyses showed that PNI<44.8 (P = 0.028) was significantly associated with worse RFS in patients with stage IIA CC patients. In the multivariate analyses, PNI<44.8 (hazard ratio [HR] 2.082; 95% confidence interval [CI] 1.005-4.317; P = 0.049) independently and significantly predicted RFS.
CONCLUSION: PNI is a useful marker for predicting recurrence prognosis in post-resection patients with stage IIA CC.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant chemotherapy; Prognostic nutritional index; Stage IIA colon Cancer

Mesh:

Year:  2020        PMID: 33138968     DOI: 10.1016/j.amjsurg.2020.10.032

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy.

Authors:  Hye Seon Kang; Ah Young Shin; Chang Dong Yeo; Sung Kyoung Kim; Chan Kwon Park; Ju Sang Kim; Seung Joon Kim; Sang Haak Lee; Jin Woo Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Development and validation of a novel diagnostic model for initially clinical diagnosed gastrointestinal stromal tumors using an extreme gradient-boosting machine.

Authors:  Bozhi Hu; Chao Wang; Kewei Jiang; Zhanlong Shen; Xiaodong Yang; Mujun Yin; Bin Liang; Qiwei Xie; Yingjiang Ye; Zhidong Gao
Journal:  BMC Gastroenterol       Date:  2021-12-18       Impact factor: 3.067

3.  Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer.

Authors:  Bing Yan; Jianmei Xiong; Qianwen Ye; Tianhui Xue; Jia Xiang; Mingyue Xu; Fang Li; Wei Wen
Journal:  BMC Gastroenterol       Date:  2022-03-16       Impact factor: 3.067

4.  Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.

Authors:  Mitsutoshi Ishii; Tetsuro Tominaga; Takashi Nonaka; Shosaburo Oyama; Masaaki Moriyama; Keizaburo Maruyama; Terumitsu Sawai; Takeshi Nagayasu
Journal:  PLoS One       Date:  2022-10-04       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.